The novel HCV TCR described herein exhibits CD8-independent target cell-recognition since the HCV TCR-transduced CD4+ T cells could secret interferon-γ and IL-2 when stimulated with peptide-loaded targets or HCV+ HCC cells (Figure 6B and Figure S3). The gene discussed is CD8A; the disease is hepatocellular carcinoma.